Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply  by Fananapazir, Lameh et al.
less than in our patients. The importance of systolic compression
of septal branches is unknown, and it would be difficult to assess in
the presence of important LAD bridging and underfilling of septal
perforators. There would be expected to be important colinearity
(correlation) between the presence of LAD bridging and septal
perforator compression, which would complicate entry of both
variables into multivariable models.
Likewise, significant colinearity would be expected between
septal wall thickness and septal perforator compression. It would
appear that LV outflow gradients were skewed in distribution and
would require a normalizing data transformation before analysis.
The analysis and conclusions are therefore flawed. It is suspected
that further analysis restricted to their subgroup of patients with
near complete systolic compression of the proximal to mid-LAD
would show similar findings to our study.
Our greatest concern is that the investigators have not per-
formed a comparable study and have not provided comparable
evidence to refute our finding that significant bridging of the LAD
is an important and treatable cause of myocardial ischemia and sudden
death in selected children with hypertrophic cardiomyopathy. Uncrit-
ical acceptance of their findings may mislead clinicians and patients.
We reassert that resolution of this controversy will require a well-
designed prospective cohort study, followed by a clinical trial of
surgical division of clinically significant myocardial bridges.
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REPLY
The report by Yetman et al. (1) that bridging of the left anterior
descending (LAD) artery causes myocardial ischemia, arrhythmia,
and sudden death in children with hypertrophic cardiomyopathy
(HCM) prompted us to examine the clinical correlates of myocar-
dial bridging in a larger population of HCM children using current
techniques and risk evaluation (2).
Myocardial bridging was present in 40% of our children, and it
frequently affected arteries other than the LAD. Myocardial ischemia
was also common, being present in 65% of the children. Notably,
however, the distribution of myocardial perfusion abnormalities,
identified by exercise thallium scintigraphy, was unrelated to the
presence, severity, or distribution of coronary bridging. Instead, we
found that myocardial bridging was more common in children with
more severe cardiac disease. Indeed, multivariate analysis suggested
that the severity of the cardiac hypertrophy and the compression of
septal branches were independent predictors of myocardial ischemia.
We were unable to confirm that myocardial bridging was
associated with greater symptoms, prolonged myocardial repolar-
ization, higher incidence of ventricular tachycardia (VT) during
ambulatory electrocardiographic monitoring, or VT induced at
electrophysiologic study, or, importantly, that it affected prognosis.
The different findings may be attributed to several limitations of
the study of Yetman et al. (1): 1) children treated as early as the
1950s were included; 2) two-thirds of the children were excluded
due to inadequate data; 3) bridging was diagnosed by, presumably,
aortography rather than selective coronary angiography (only
severe and mid-LAD bridging were detected); 4) survival was
calculated from diagnosis of HCM rather than related to age (the
children with bridging were older and in a more at-risk age group
than were the children without bridging); and 5) compression of
the septal perforators, an important determinant of myocardial
perfusion in our study, was not considered. Further, given the
limitations of angiography, we have reservations about the validity
of measurements of early diastolic coronary artery compression.
In children, HCM is a complex disease, and myocardial isch-
emia is only one of several identified potential causes of sudden
death in this subgroup (3). Additionally, several factors unrelated
to bridging have also been implicated in myocardial ischemia (4).
Our study indicates that it is unlikely that bridging is an
independent predictor of prognosis in HCM children. We there-
fore recommend caution in advising its surgical correction.
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